Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Treatment of HCC with Lenvatinib or Regorafenib in combination with Cdk5 inhibition – a new promising therapeutic approach to improve the situation of HCC patients

#2021

PMU Author
Petra Huber-Cantonati

All Authors
Petra Huber-Cantonati, L. Kraus, M. A. Ardelt, J. Pachmayr

Abstract

We are sorry. The full text is not available.